Skip to main content
Top
Published in: BMC Gastroenterology 1/2020

Open Access 01-12-2020 | Ulcerative Colitis | Research article

Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients

Authors: Hassan Ashktorab, Hassan Brim, Sally Hassan, Mehdi Nouraie, Agazi Gebreselassie, Adeyinka O. Laiyemo, Angesom Kibreab, Farshad Aduli, Giovanni Latella, Steven R. Brant, Zaki Sherif, Aida Habtezion

Published in: BMC Gastroenterology | Issue 1/2020

Login to get access

Abstract

Background

Colitis is generally considered a risk factor for colon neoplasia. However, not all types of colitis seem to have equal neoplastic transformation potential.

Aim

To determine the prevalence of colorectal polyps in a predominantly African American population with inflammatory bowel disease (IBD) and Non-IBD/Non-Infectious Colitis (NIC).

Methods

We retrospectively evaluated medical records of 1060 patients previously identified with colitis at Howard University Hospital, based on ICD-10 code. Among these, 485 patients were included in the study: 70 IBD and 415 NIC based on a thorough review of colonoscopy, pathology and clinical reports. Logistic regression analysis was applied to estimate the risk of polyps in patients with IBD compared to those with NIC after adjusting for age and sex. A subgroup analysis within the IBD group was performed.

Results

Of the 485 patients, 415 were NIC and 70 were IBD. Seventy-three percent of the NIC patients and 81% of the IBD patients were African Americans. Forty six percent of IBD and 41% of NIC cases were male. IBD patients were younger than NIC patients (median age of 38 years vs. 50, P < 0.001). The prevalence of all types of polyps was 15.7 and 8.2% in the IBD and NIC groups, respectively (P = 0.045). Among patients with polyps, the prevalence of inflammatory polyps was higher in the IBD group (55%) compared to the NIC group (12%). After adjusting for age, sex and race, odds ratio of inflammatory polyps in IBD patients was 6.0 (P = 0.016). Adenoma prevalence was 4.3% (3/70) in IBD patients and 3.9% (16/415) in the NIC patients (p = 0.75). The anatomic distribution of lesions and colitis shows that polyps occur predominantly in the colitis field regardless of colitis type. More polyps were present in the ulcerative colitis patients when compared to Crohn’s disease patients (27% vs. 5%, P < 0.001) within the IBD group.

Conclusion

Our study shows that inflammatory polyps are more common in IBD patients when compared to NIC patients. Most polyps were in the same location as the colitis.
Literature
1.
go back to reference Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.CrossRef Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(Suppl A):5A–36A.CrossRef
2.
go back to reference Haagen Nielsen O, Vainer B, Rask-Madsen J. Non-IBD and noninfectious colitis. Nat Clin Pract Gastroenterol Hepatol. 2008;5(1):28–39. Haagen Nielsen O, Vainer B, Rask-Madsen J. Non-IBD and noninfectious colitis. Nat Clin Pract Gastroenterol Hepatol. 2008;5(1):28–39.
3.
go back to reference Thorsen AJ. Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis. Clin Colon Rectal Surg. 2007;20(1):47–57.CrossRef Thorsen AJ. Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis. Clin Colon Rectal Surg. 2007;20(1):47–57.CrossRef
4.
go back to reference Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ. Surveillance of patients with chronic ulcerative colitis. WHO collaborating Centre for the Prevention of colorectal Cancer. Bull World Health Organ. 1991;69(1):121–6.PubMedPubMedCentral Levin B, Lennard-Jones J, Riddell RH, Sachar D, Winawer SJ. Surveillance of patients with chronic ulcerative colitis. WHO collaborating Centre for the Prevention of colorectal Cancer. Bull World Health Organ. 1991;69(1):121–6.PubMedPubMedCentral
5.
go back to reference Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clinical Gastroenterology Hepatology. 2018;16(2):190–7 e111.CrossRef Shi HY, Levy AN, Trivedi HD, Chan FKL, Ng SC, Ananthakrishnan AN. Ethnicity influences phenotype and outcomes in inflammatory bowel disease: a systematic review and meta-analysis of population-based studies. Clinical Gastroenterology Hepatology. 2018;16(2):190–7 e111.CrossRef
6.
go back to reference Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohn's Colitis. 2013;7(12):968–73.CrossRef Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. J Crohn's Colitis. 2013;7(12):968–73.CrossRef
7.
go back to reference Nazar PS, Smishchuk Iu O. The mucosal status of the large intestine in the irritable bowel syndrome and in chronic noninfectious nonspecific colitis. Lik Sprava. 1998;7:111–4. Nazar PS, Smishchuk Iu O. The mucosal status of the large intestine in the irritable bowel syndrome and in chronic noninfectious nonspecific colitis. Lik Sprava. 1998;7:111–4.
8.
go back to reference Taylor SF, Sondheimer JM, Sokol RJ, Silverman A, Wilson HL. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr. 1991;119(1 Pt 1):24–8.CrossRef Taylor SF, Sondheimer JM, Sokol RJ, Silverman A, Wilson HL. Noninfectious colitis associated with short gut syndrome in infants. J Pediatr. 1991;119(1 Pt 1):24–8.CrossRef
9.
go back to reference Zernov NG, Shestakova NG. Chronic colitis of noninfectious etiology in children. Pediatriia. 1983;9:36–9. Zernov NG, Shestakova NG. Chronic colitis of noninfectious etiology in children. Pediatriia. 1983;9:36–9.
10.
go back to reference Sonnenberg A. Review article: historic changes of helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38(4):329–42.CrossRef Sonnenberg A. Review article: historic changes of helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38(4):329–42.CrossRef
11.
go back to reference Chiu HH, Chen CM, Mo LR, Chao TJ. Gastrointestinal: ischemic colitis associated with colon cancer. J Gastroenterol Hepatol. 2005;20(9):1458.CrossRef Chiu HH, Chen CM, Mo LR, Chao TJ. Gastrointestinal: ischemic colitis associated with colon cancer. J Gastroenterol Hepatol. 2005;20(9):1458.CrossRef
12.
go back to reference Morioka T, Miyoshi-Imamura T, Blyth BJ, Kaminishi M, Kokubo T, Nishimura M, Kito S, Tokairin Y, Tani S, Murakami-Murofushi K, et al. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice. Cancer Sci. 2015;106(3):217–26.CrossRef Morioka T, Miyoshi-Imamura T, Blyth BJ, Kaminishi M, Kokubo T, Nishimura M, Kito S, Tokairin Y, Tani S, Murakami-Murofushi K, et al. Ionizing radiation, inflammation, and their interactions in colon carcinogenesis in Mlh1-deficient mice. Cancer Sci. 2015;106(3):217–26.CrossRef
13.
go back to reference Wu XR, Kiran RP, Remzi FH, Katz S, Mukewar S, Shen B. Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohn's Colitis. 2013;7(10):e419–26.CrossRef Wu XR, Kiran RP, Remzi FH, Katz S, Mukewar S, Shen B. Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. J Crohn's Colitis. 2013;7(10):e419–26.CrossRef
14.
go back to reference Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterology Hepatology. 2014;12(5):756–64. Wanders LK, Dekker E, Pullens B, Bassett P, Travis SP, East JE. Cancer risk after resection of polypoid dysplasia in patients with longstanding ulcerative colitis: a meta-analysis. Clin Gastroenterology Hepatology. 2014;12(5):756–64.
15.
go back to reference Brim H, Yooseph S, Zoetendal EG, Lee E, Torralbo M, Laiyemo AO, Shokrani B, Nelson K, Ashktorab H. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One. 2013;8(12):e81352.CrossRef Brim H, Yooseph S, Zoetendal EG, Lee E, Torralbo M, Laiyemo AO, Shokrani B, Nelson K, Ashktorab H. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One. 2013;8(12):e81352.CrossRef
16.
go back to reference Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8.CrossRef Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635–8.CrossRef
17.
go back to reference Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–9.CrossRef Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science. 2006;312(5778):1355–9.CrossRef
18.
go back to reference Ashktorab H, Hassanzadeh Namin H, Taylor T, Williams C, Brim H, Mellman T, Shokrani B, Holt CL, Laiyemo AO, Nouraie M. Role of life events in the presence of colon polyps among African Americans. BMC Gastroenterol. 2013;13(1):101.CrossRef Ashktorab H, Hassanzadeh Namin H, Taylor T, Williams C, Brim H, Mellman T, Shokrani B, Holt CL, Laiyemo AO, Nouraie M. Role of life events in the presence of colon polyps among African Americans. BMC Gastroenterol. 2013;13(1):101.CrossRef
19.
go back to reference Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Kumar S, Green B, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158(2):288–99.CrossRef Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Kumar S, Green B, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158(2):288–99.CrossRef
20.
go back to reference Takahashi H, Hosono K, Endo H, Nakajima A. Colon epithelial proliferation and carcinogenesis in diet-induced obesity. J Gastroenterol Hepatol. 2013;28(Suppl 4):41–7.CrossRef Takahashi H, Hosono K, Endo H, Nakajima A. Colon epithelial proliferation and carcinogenesis in diet-induced obesity. J Gastroenterol Hepatol. 2013;28(Suppl 4):41–7.CrossRef
21.
go back to reference Dixon A, Wurm P, Hart A, Robinson R. Distal adenomatous polyps are rare in patients with inflammatory bowel disease. Postgrad Med J. 2006;82(963):76–8.CrossRef Dixon A, Wurm P, Hart A, Robinson R. Distal adenomatous polyps are rare in patients with inflammatory bowel disease. Postgrad Med J. 2006;82(963):76–8.CrossRef
22.
go back to reference Lee LH, Iacucci M, Fort Gasia M, Ghosh S, Panaccione R, Urbanski S. Prevalence and anatomic distribution of serrated and adenomatous lesions in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017;2017:5490803.CrossRef Lee LH, Iacucci M, Fort Gasia M, Ghosh S, Panaccione R, Urbanski S. Prevalence and anatomic distribution of serrated and adenomatous lesions in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2017;2017:5490803.CrossRef
23.
go back to reference Stidham RW, Higgins PDR. Colorectal Cancer in inflammatory bowel disease. Clin Colon Rectal Surg. 2018;31(3):168–78.CrossRef Stidham RW, Higgins PDR. Colorectal Cancer in inflammatory bowel disease. Clin Colon Rectal Surg. 2018;31(3):168–78.CrossRef
24.
go back to reference Heinze G, Puhr R. Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets. Stat Med. 2010;29(7–8):770–7.CrossRef Heinze G, Puhr R. Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets. Stat Med. 2010;29(7–8):770–7.CrossRef
25.
go back to reference Iacucci M, Uraoka T, Fort Gasia M, Yahagi N. Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2014;28(7):361–70.CrossRef Iacucci M, Uraoka T, Fort Gasia M, Yahagi N. Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol. 2014;28(7):361–70.CrossRef
26.
go back to reference Tan YG, Zhang YF, Guo CJ, Yang M, Chen MY. Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer. Asian Pac J Trop Med. 2013;6(12):972–6.CrossRef Tan YG, Zhang YF, Guo CJ, Yang M, Chen MY. Screening of differentially expressed microRNA in ulcerative colitis related colorectal cancer. Asian Pac J Trop Med. 2013;6(12):972–6.CrossRef
27.
go back to reference McLarnon A. IBD: risk of colorectal cancer in African Americans with ulcerative colitis. Nat Rev Gastroenterol Hepatol. 2011;8(11):598.CrossRef McLarnon A. IBD: risk of colorectal cancer in African Americans with ulcerative colitis. Nat Rev Gastroenterol Hepatol. 2011;8(11):598.CrossRef
28.
go back to reference Wang YR, Loftus EV Jr, Cangemi JR, Picco MF. Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013;88(1):20–5.CrossRef Wang YR, Loftus EV Jr, Cangemi JR, Picco MF. Racial/ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States. Digestion. 2013;88(1):20–5.CrossRef
29.
go back to reference Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22(8):2023–40.CrossRef Afzali A, Cross RK. Racial and ethnic minorities with inflammatory bowel disease in the United States: a systematic review of disease characteristics and differences. Inflamm Bowel Dis. 2016;22(8):2023–40.CrossRef
30.
go back to reference Galoosian A, Rezapour M, Liu B, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. J Clin Gastroenterology. 2019. Galoosian A, Rezapour M, Liu B, Bhuket T, Wong RJ. Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States. J Clin Gastroenterology. 2019.
31.
go back to reference Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, et al. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018;48(9):933–40.CrossRef Anyane-Yeboa A, Yamada A, Haider H, Wang Y, Komaki Y, Komaki F, Pekow J, Dalal S, Cohen RD, Cannon L, et al. A comparison of the risk of postoperative recurrence between African-American and Caucasian patients with Crohn's disease. Aliment Pharmacol Ther. 2018;48(9):933–40.CrossRef
32.
go back to reference White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, Cohen SA, Baldassano RN, Smith T, Clemons T, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterology Hepatology. 2008;6(12):1361–9.CrossRef White JM, O'Connor S, Winter HS, Heyman MB, Kirschner BS, Ferry GD, Cohen SA, Baldassano RN, Smith T, Clemons T, et al. Inflammatory bowel disease in African American children compared with other racial/ethnic groups in a multicenter registry. Clin Gastroenterology Hepatology. 2008;6(12):1361–9.CrossRef
33.
go back to reference Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–97.CrossRef Yashiro M. Ulcerative colitis-associated colorectal cancer. World J Gastroenterol. 2014;20(44):16389–97.CrossRef
34.
go back to reference Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2009;6(5):297–305.CrossRef Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol. 2009;6(5):297–305.CrossRef
35.
go back to reference Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol. 2011;11(1):9–20.CrossRef Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol. 2011;11(1):9–20.CrossRef
36.
go back to reference Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012;3:107.CrossRef Rubin DC, Shaker A, Levin MS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol. 2012;3:107.CrossRef
37.
go back to reference Foersch S, Neurath MF. Colitis-associated neoplasia: molecular basis and clinical translation. Cell Mol Life Sci. 2014;71(18):3523–35.CrossRef Foersch S, Neurath MF. Colitis-associated neoplasia: molecular basis and clinical translation. Cell Mol Life Sci. 2014;71(18):3523–35.CrossRef
38.
go back to reference Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56(1):48–54.CrossRef Soetikno RM, Lin OS, Heidenreich PA, Young HS, Blackstone MO. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56(1):48–54.CrossRef
39.
go back to reference Thackeray EW, Charatcharoenwitthaya P, Elfaki D, Sinakos E, Lindor KD. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterology Hepatology. 2011;9(1):52–6.CrossRef Thackeray EW, Charatcharoenwitthaya P, Elfaki D, Sinakos E, Lindor KD. Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis. Clin Gastroenterology Hepatology. 2011;9(1):52–6.CrossRef
40.
go back to reference Abou Rached A, Saba J, El Masri L, Nakhoul M, Razzouk C. Obstructive Giant inflammatory polyposis: is it related to the severity or the duration of the inflammatory bowel disease? Two Case Reports. Case Rep Gastrointest Med. 2018;2018:3251549.PubMedPubMedCentral Abou Rached A, Saba J, El Masri L, Nakhoul M, Razzouk C. Obstructive Giant inflammatory polyposis: is it related to the severity or the duration of the inflammatory bowel disease? Two Case Reports. Case Rep Gastrointest Med. 2018;2018:3251549.PubMedPubMedCentral
Metadata
Title
Inflammatory polyps occur more frequently in inflammatory bowel disease than other colitis patients
Authors
Hassan Ashktorab
Hassan Brim
Sally Hassan
Mehdi Nouraie
Agazi Gebreselassie
Adeyinka O. Laiyemo
Angesom Kibreab
Farshad Aduli
Giovanni Latella
Steven R. Brant
Zaki Sherif
Aida Habtezion
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2020
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-020-01279-y

Other articles of this Issue 1/2020

BMC Gastroenterology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.